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I know Dr Cockcroft feels as I do that 'It is essential that guidance from DH is, where possible, based on robust evidence', as he recently stated in a CDO newsletter. 2 As if to reinforce to us all how critical it is to get centralised guidance right before its imposition, Dr Cockcroft explains the consequences of not following such newly created guidance to the letter, bringing down the wrath of legislation in NHS regulations, the new Care Quality Commission and even Fitness to Practise GDC disciplinary procedures to bear on anyone who dare vary or question such guidance! It may be of course that the unavailable 60 plus references alluded to in Dr Cockcroft's reply* meet the highest evidence standards of Cochrane level 4 or even level 3 GRADE 3 quality, so I am mystifi ed as to why these have never been produced for public or professional scrutiny. Indeed if they are so reliable/compelling that would be reassuring. If, however, they are at the lowest GRADE 1 of evidence (expert opinion and poorly controlled trials) then surely one must question whether such extensive, expensive and potentially retrograde changes purporting to be 'best practice', should be made compulsory before any such high-quality evidence is further commissioned and evaluated. Given the existing publicly available evidence that vCJD deaths have only totalled 167 over 20 years, are in steep decline since their peak in 2000 and it is predicted there will only be one or two new vCJD cases occurring per year now, one must ask why then this HTM 01-05 disproportionate response when NO cases have ever been associated with dentistry? 4 Any risk assessment should take into account 'Failure Modes' and 'Effects Analysis' (FMEA), where failure modes are any defects in a process, design or item (eg: WDs) and effect analysis looks at the effects of those failures. 5 Immediately the published literature would raise FMEA concerns where proposed HTM 01-05 'best practice' methods using hightemperature washer disinfectors (WD) leave signifi cant amounts of proteins on sterilised instruments consistently. [6] [7] [8] [9] [10] Thus for such decontamination stages pre-autoclaving, shouldn't emphasis be on ensuring existing protocols are used routinely, 11 physical scrubbing, 12 ordinary washers operating at lower temperatures that don't bake on proteins, 13 or/ and an ultrasonic bath stages 14 as used currently, which have lower FMEA risks and provide safer, superior and more evidence-based results than those about to be enforced in HTM 01-05 best practice? I can do no better than quote the DH's own report in 2006 15 looking at current WDs/autoclaving systems which states, '…the high levels of retained protein burden after decontamination through typical NHS systems is itself a matter for concern'. We need scientifi c validation fi rst, otherwise printer-validation on hightemperature WDs may simply prove we have left 'high levels of retained protein burden' on all our dental instruments instead -I can just imagine patient consent to that not being very popular! 
JUMPING THE GUN
Sir, I was surprised to read in the letter from V. Ballal entitled Oil therapy (BDJ 2009; 207: 193) that the literature has reported that swishing sunfl ower oil around the mouth for 15 minutes a day can 'effectively treat … meningitis, heart and kidney disorders, women's hormonal disorders, and chronic diseases like cancer, AIDS etc.' However, no references were provided and a cursory search of the literature found only studies examining oil pulling as a means of managing oral bacteria. The claims of effectiveness against a long list of unrelated conditions, as well as the references to toxins, healing 'all organs simultaneously' and an unknown mechanism, are all reminiscent of the language used to promote unproven or disproven alternative remedies. Oil pulling may or may not prove a useful technique, but for traditional remedies to enter the folds of evidencebased medicine it is important to investigate any real effects they may have without being distracted by illusory effects ascribed to them by their advocates. Without strong evidence that oil pulling has an effect beyond those of placebo and a thorough oral rinse, the suggested research to discover the source of this effect would seem to be jumping the gun.
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NOT RECOMMENDED
Sir, with reference to the letter Oil therapy published in your journal (BDJ 2009; 207: 193) we would like to share our experience on this.
We treated a case of severe infl ammatory gingival enlargement in a 48-year-old female. She was suffering from swollen and bleeding gums for which was suggested, as treatment, oil pulling (OP) using refi ned sunfl ower oil by a friend who was also practising OP. She had performed OP for three months and had observed that her problem was worsening. When we saw her, we noticed generalised gingival enlargement, multiple false deep periodontal pockets and mild sub-gingival calculus deposits. She was healthy and was not taking any kind of medication. We suggested she stop OP and reviewed her case after three weeks; her gingival infl ammation had substantially reduced. Following this she was treated with conventional periodontal therapy and her gingival health became normal. We feel because of the retention of oil particles in her sub-gingival tissues her gingival health had worsened.
OP therapy has been shown to reduce plaque index 1 as well as Streptococcus mutans count in plaque and saliva. 2 We are of the opinion that until the benefi ts and indications for OP are documented and established scientifi cally it should not be recommended. 
TUBERCULOSIS DIAGNOSIS
Sir, a 37-year-old woman was referred by her general medical practitioner with a two-month history of an increasing right-sided facial swelling. She has been resident in the UK for ten years with no history of cough, weight loss or recent travel. On examination, there was a 3 cm raised, fl uctuant lesion on the lower border of the mandible (Fig. 1) 
HELP TO QUIT
Sir, tobacco use is one of the major preventable causes of health damage and death in India. It is estimated that tobacco will kill 6 million people annually from 2010, 80% of which will happen in low and middle income countries like India. 1 The most susceptible age for initiating tobacco use in India is during adolescence and early childhood with most users starting use before the age of 18 years, while some start as young as ten years. Studies show that if people do not begin to use tobacco during adolescence, there is a good chance they never will. Each day about 5,500 children in India start using tobacco and join about 5 million children under the age of 15 years who are already addicted to tobacco. Adolescent tobacco use is characterised by being driven by relationships, activities, positive and negative emotions and social ramifi cations while adult tobacco use is defi ned by nicotine dependence. According to the Global Youth Tobacco Survey (GYTS) (2000) (2001) (2002) (2003) (2004) including students from grades 8-10 in India, 17.5% were current users of tobacco in any form, 14.6% were using smokeless
